S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
Musk says Twitter deal could move ahead with 'bot' info
Demand for grocery delivery cools as food costs rise
Dems' climate, energy, tax bill clears initial Senate hurdle
Shift in war's front seen as ships cleared to leave Ukraine
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
Musk says Twitter deal could move ahead with 'bot' info
Demand for grocery delivery cools as food costs rise
Dems' climate, energy, tax bill clears initial Senate hurdle
Shift in war's front seen as ships cleared to leave Ukraine
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
Musk says Twitter deal could move ahead with 'bot' info
Demand for grocery delivery cools as food costs rise
Dems' climate, energy, tax bill clears initial Senate hurdle
Shift in war's front seen as ships cleared to leave Ukraine
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
Musk says Twitter deal could move ahead with 'bot' info
Demand for grocery delivery cools as food costs rise
Dems' climate, energy, tax bill clears initial Senate hurdle
Shift in war's front seen as ships cleared to leave Ukraine
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
NASDAQ:FREQ

Frequency Therapeutics (FREQ) Stock Forecast, Price & News

$2.23
-0.02 (-0.89%)
(As of 08/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$2.21
$2.31
50-Day Range
$1.03
$2.55
52-Week Range
$1.00
$8.60
Volume
210,323 shs
Average Volume
527,027 shs
Market Capitalization
$78.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.50

Frequency Therapeutics MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
326.0% Upside
$9.50 Price Target
Short Interest
Healthy
2.75% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$10,118 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.51) to ($1.27) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.63 out of 5 stars

Medical Sector

113th out of 1,283 stocks

Pharmaceutical Preparations Industry

42nd out of 615 stocks

Frequency Therapeutics logo

About Frequency Therapeutics (NASDAQ:FREQ) Stock

Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts.

Frequency Therapeutics Price Performance

Shares of Frequency Therapeutics stock traded down $0.02 during midday trading on Friday, hitting $2.23. 210,323 shares of the company traded hands, compared to its average volume of 527,027. The stock has a market cap of $78.01 million, a price-to-earnings ratio of -0.88 and a beta of 0.78. The company has a debt-to-equity ratio of 0.10, a quick ratio of 9.85 and a current ratio of 9.85. The firm's fifty day moving average price is $1.63 and its 200-day moving average price is $2.23. Frequency Therapeutics has a 12 month low of $1.00 and a 12 month high of $8.60.

Frequency Therapeutics (NASDAQ:FREQ - Get Rating) last announced its quarterly earnings results on Wednesday, May 4th. The company reported ($0.67) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.66) by ($0.01). As a group, sell-side analysts forecast that Frequency Therapeutics will post -2.51 earnings per share for the current year.

Receive FREQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Frequency Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

FREQ Stock News Headlines

27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate. pixel
Frequency Therapeutics GAAP EPS of -$0.67
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile. Take your trading to the next level with the Options Strategy Guide. pixel
Frequency Exchange Corp. Virtually Closes the Market
Why Are Altamira Therapeutics Shares Gaining Today?
See More Headlines

Receive FREQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Frequency Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

FREQ Company Calendar

Last Earnings
11/15/2021
Today
8/07/2022
Next Earnings (Estimated)
8/11/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:FREQ
Fax
N/A
Employees
72
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$9.50
High Stock Price Forecast
$10.00
Low Stock Price Forecast
$9.00
Forecasted Upside/Downside
+326.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-84,690,000.00
Pretax Margin
-930.98%

Debt

Sales & Book Value

Annual Sales
$14.07 million
Book Value
$3.78 per share

Miscellaneous

Free Float
29,835,000
Market Cap
$78.01 million
Optionable
Not Optionable
Beta
0.78

Key Executives














FREQ Stock - Frequently Asked Questions

Should I buy or sell Frequency Therapeutics stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Frequency Therapeutics in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Frequency Therapeutics stock.
View analyst ratings for Frequency Therapeutics
or view top-rated stocks.

What is Frequency Therapeutics' stock price forecast for 2022?

2 analysts have issued 1-year target prices for Frequency Therapeutics' shares. Their FREQ stock forecasts range from $9.00 to $10.00. On average, they anticipate Frequency Therapeutics' share price to reach $9.50 in the next year. This suggests a possible upside of 326.0% from the stock's current price.
View analysts' price targets for Frequency Therapeutics
or view top-rated stocks among Wall Street analysts.

How has Frequency Therapeutics' stock performed in 2022?

Frequency Therapeutics' stock was trading at $5.13 at the start of the year. Since then, FREQ shares have decreased by 56.5% and is now trading at $2.23.
View the best growth stocks for 2022 here
.

Are investors shorting Frequency Therapeutics?

Frequency Therapeutics saw a drop in short interest in the month of July. As of July 15th, there was short interest totaling 881,700 shares, a drop of 16.8% from the June 30th total of 1,060,000 shares. Based on an average daily volume of 642,800 shares, the days-to-cover ratio is presently 1.4 days. Approximately 2.8% of the shares of the company are short sold.
View Frequency Therapeutics' Short Interest
.

When is Frequency Therapeutics' next earnings date?

Frequency Therapeutics is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022.
View our earnings forecast for Frequency Therapeutics
.

How were Frequency Therapeutics' earnings last quarter?

Frequency Therapeutics, Inc. (NASDAQ:FREQ) posted its quarterly earnings data on Monday, November, 15th. The company reported ($0.73) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.57) by $0.16.

What other stocks do shareholders of Frequency Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Frequency Therapeutics investors own include AbbVie (ABBV), Fulcrum Therapeutics (FULC), Akero Therapeutics (AKRO), Advanced Micro Devices (AMD), Pfizer (PFE), Taiwan Semiconductor Manufacturing (TSM), Atreca (BCEL), Cidara Therapeutics (CDTX), Clovis Oncology (CLVS) and Chimerix (CMRX).

When did Frequency Therapeutics IPO?

(FREQ) raised $102 million in an initial public offering (IPO) on Thursday, October 3rd 2019. The company issued 6,700,000 shares at $14.50-$16.00 per share. J.P. Morgan, Goldman Sachs and Cowen acted as the underwriters for the IPO and Mizuho Securities was co-manager.

What is Frequency Therapeutics' stock symbol?

Frequency Therapeutics trades on the NASDAQ under the ticker symbol "FREQ."

Who are Frequency Therapeutics' major shareholders?

Frequency Therapeutics' stock is owned by many different retail and institutional investors. Top institutional investors include Waldron Private Wealth LLC (0.20%), Centaurus Financial Inc. (0.06%) and Essex Financial Services Inc. (0.06%). Company insiders that own Frequency Therapeutics stock include Carl Lebel, Christopher R Loose, David L Lucchino, James E Flynn, Joel S Marcus, Marc A Cohen, Peter P Pfreundschuh, Quentin Mccubbin and Richard J Mitrano.
View institutional ownership trends for Frequency Therapeutics
.

How do I buy shares of Frequency Therapeutics?

Shares of FREQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Frequency Therapeutics' stock price today?

One share of FREQ stock can currently be purchased for approximately $2.23.

How much money does Frequency Therapeutics make?

Frequency Therapeutics (NASDAQ:FREQ) has a market capitalization of $78.01 million and generates $14.07 million in revenue each year. The company earns $-84,690,000.00 in net income (profit) each year or ($2.54) on an earnings per share basis.

How many employees does Frequency Therapeutics have?

Frequency Therapeutics employs 72 workers across the globe.

How can I contact Frequency Therapeutics?

Frequency Therapeutics' mailing address is 19 PRESIDENTIAL WAY SUITE 203, WOBURN MA, 01801. The official website for Frequency Therapeutics is www.frequencytx.com. The company can be reached via phone at 781-315-4600 or via email at investorrelations@frequencytx.com.

This page (NASDAQ:FREQ) was last updated on 8/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.